Literature DB >> 9378552

The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites.

R Newton1, J Ferlay, V Beral, S S Devesa.   

Abstract

International population-based cancer incidence data, coded according to the International Classification of Diseases for Oncology (WHO, 1990), were used to describe geographical patterns of incidence of extra-nodal non-Hodgkin's lymphomas. Incidence data from the USA were also used to describe age and sex distribution of lymphomas at different extranodal sites. The percentage of all non-Hodgkin's lymphomas coded as being of extra-nodal origin is between 25% and 35% in most countries, with the stomach, skin and small intestine being the most common extra-nodal sites. In general, the pattern of incidence rates for extra-nodal lymphomas tends to reflect that of other lymphomas. For example, the age incidence curve of each site-specific extra-nodal lymphoma is similar to that of nodal lymphomas, and in countries where total lymphoma incidence is high the incidence of lymphomas at each extra-nodal site also tends to be relatively high. Although specific factors are known to increase the risk of lymphomas at certain anatomical sites, these data suggest that the aetiology of extra-nodal lymphomas is not entirely independent from that of nodal lymphomas.

Entities:  

Mesh:

Year:  1997        PMID: 9378552     DOI: 10.1002/(sici)1097-0215(19970917)72:6<923::aid-ijc1>3.0.co;2-r

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

Authors:  T Mitterlechner; M Fiegl; H Mühlböck; W Oberaigner; S Dirnhofer; A Tzankov
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

3.  Histopathological Features and Ann Arbor Stage in Periocular Lymphoma.

Authors:  Marco Zschoche; Annette Zimpfer; Björn O Scheef; Anselm M Jünemann; Rudolf F Guthoff; Christian Junghanss; Guido Hildebrandt; Steffen Emmert; Andreas Erbersdobler; Günther Kundt; Vinodh Kakkassery
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

4.  A Case of Primary Bone Marrow B-Cell Non Hodgkin's Lymphoma with Severe Thrombocytopenia: Case Report and A Review of the Literature.

Authors:  Yuki Kagoya; Naohi Sahara; Takashi Matsunaga; Toshimasa Uekusa; Seiji Irie; Kazuhito Hatanaka
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-06       Impact factor: 0.900

5.  Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population.

Authors:  Jenika M Howell; Iwona Auer-Grzesiak; Jianguo Zhang; Christopher N Andrews; Douglas Stewart; Stefan J Urbanski
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

6.  Primary Urinary Tract Lymphoma: Rare but Aggressive.

Authors:  Konstantinos Lontos; Anastasia Tsagianni; Pavlos Msaouel; Leonard Joseph Appleman; Dimitrios Nasioudis
Journal:  Anticancer Res       Date:  2017-12       Impact factor: 2.480

Review 7.  [Extranodal abdominal lymphomas].

Authors:  T F Weber; S Dietrich; J Nattenmüller
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

8.  Disseminated non-Hodgkin's lymphoma presenting as bilateral salivary gland enlargement: a case report.

Authors:  Manjunatha M Revanappa; Atul P Sattur; Venkatesh G Naikmasur; Arpita Rai Thakur
Journal:  Imaging Sci Dent       Date:  2013-03-11

9.  Extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma of cecum presenting as bright red bleed per rectum--a case report with review of literature.

Authors:  Rohtesh S Mehta; Niyati Modi; Nancy Sapanara; Prashanth Ramachandra; Michael Mikhail
Journal:  J Gastrointest Cancer       Date:  2009-02-19

10.  Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma.

Authors:  Geundoo Jang; Dok Hyun Yoon; Shin Kim; Dae Ho Lee; Sang-Wook Lee; Jooryung Huh; Cheolwon Suh
Journal:  Korean J Hematol       Date:  2011-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.